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Abstract: Galectin-3 is considered a cancer biomarker and bioindicator of fibrosis and cardiac 
remodeling and, therefore, it is desirable to develop convenient methods for its detection. Herein, 
an approach based on the development of multivalent electrochemical probes with high galectin-3 
sensing abilities is reported. The probes consist of multivalent presentations of lactose–ferrocene 
conjugates scaffolded on poly (amido amine) (PAMAM) dendrimers and gold nanoparticles. Such 
multivalent lactose–ferrocene conjugates are synthesized by coupling of azidomethyl ferrocene–
lactose building blocks on alkyne-functionalized PAMAM, for the case of the glycodendrimers, and 
to disulfide-functionalized linkers that are then used for the surface modification of citrate-
stabilized gold nanoparticles. The binding and sensing abilities toward galectin-3 of both ferrocene-
containing lactose dendrimers and gold nanoparticles have been evaluated by means of isothermal 
titration calorimetry, UV–vis spectroscopy, and differential pulse voltammetry. The highest 
sensitivity by electrochemical methods to galectin-3 was shown by lactosylferrocenylated gold 
nanoparticles, which are able to detect the lectin in nanomolar concentrations. 




Galectins are a family of β-D-galactoside-binding lectins, which are widespread throughout the 
animal kingdom and are ubiquitous in adult humans. Among these lectins, galectin-3 (Gal-3) 
occupies a prominent place due to its implications in various physiological and pathological 
processes, such as inflammation, cancer progression, and metastasis through various mechanisms, 
including cell–cell adhesion, cell–matrix interactions, apoptosis, angiogenesis, and mRNA splicing. 
Gal-3 plays a key role in triggering inflammation in many acute and chronic conditions, including 
atherosclerosis and heart failure, autoimmune diseases, neurological degeneration, and diabetes, 
among others. Gal-3 is overexpressed in many tumor cells and is considered to be a cancer biomarker 
[1]. Furthermore, high blood Gal-3 levels have been correlated with the likelihood of heart failure, 
and the protein is a novel bioindicator of fibrosis and cardiac remodeling [2–7]. Therefore, there is a 
need for the development of Gal-3 detection and monitoring methods in serum to provide useful 
information on cancer progression and cardiovascular risk. Such methods should meet the 
characteristics of convenience, inexpensiveness, and robustness. 
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Most of the reported assay methods are based on routine immunoassays [8,9], Western blot 
analysis or an enzyme-linked immunosorbent assay (ELISA) [10–12], and immunohistochemical 
methods [13,14]. However, despite the advantages of immunoassay-type methods, they exhibit many 
inherent limitations; they can be labor-intensive, expensive, and suffer from a lack of reproducibility, 
a high possibility of false positive/negative results, and a lack of stability of antibodies and enzymes 
[15,16]. 
To improve Gal-3 detection sensitivity and reproducibility, immunoassay-type methods can be 
combined with other techniques. For example, a sandwich-type electrochemical immunosensor that 
uses Gal-3 antibodies has been reported recently [17]. This method is based on MIL-88(Fe) metal–
organic framework/Au hybrid nanoparticles immobilized on N-doped graphene nanoribbons for the 
immobilization of the primary Gal-3 antibody and involves AuPt-methylene blue. The latter is a 
redox nanoprobe for the generation and amplification of electrochemical signals. Although direct 
detection of Gal-3 by means of surface plasmon resonance (SPR) measurements using lactose-
modified gold surfaces has been reported [18], an optical biosensor that uses the anti-Gal-3 antibody 
as a biorecognition element has been developed for the quantification of Gal-3 based on a graphene 
oxide-enhanced SPR methodology for transducing the immunological interaction [19]. 
Efforts to develop alternative sensing methods include the use of galactose-containing chemical 
probes. A biotinylated N-acetyl lactosamine–polyacrylamide conjugate has been used as a probe for 
Gal-3 sensing in a sandwich-type assay. The immobilized lectin bound to the conjugate is detected 
by means of the enhanced chemiluminescence of horseradish peroxidase–streptavidin bound to the 
probe [20]. 
Synthesized molecular probes with an enhanced affinity to Gal-3 have been applied in optical 
Gal-3 sensing. This method consists of using ligands, such as lactose or thiodigalactoside derivatives 
bearing a photo label for covalent attachment to Gal-3 upon binding and photoirradiation, and an 
azido or propargyl group for the subsequent “clicking” of fluorescent derivatives for in-gel 
visualization of the protein [21–24]. 
Furthermore, the synthesis of a lactose derivative containing a lanthanide-binding tag allows for 
the use of such ligands as a molecular probe for sensing Gal-3 through NMR measurements, thereby 
exploiting the paramagnetic effects of the presence of the lanthanide cation [25]. 
However, the development of electrochemical probes for the detection of Gal-3 is very scarce. 
So far, to the best of our knowledge, only two reported examples involve the use of electrochemical 
methods [17,26]. Of them, only one is based on the use of a Gal-3 ligand probe; that is, galactose-
containing single-walled carbon nanotubes [26]. 
Electrochemical sensors have found a wide range of applications in industrial, environmental, 
clinical, agricultural, and food analysis. Such devices present some advantages. For example, they 
can be used for direct measurements in complex matrices, they are susceptible to miniaturization, 
and they can provide rapid, highly sensitive, reliable, and inexpensive measurements [27–30]. 
We previously reported on the redox and sensing ability properties of carbohydrate and 
peptide–ferrocene conjugates toward proteins [31–39]. An interesting finding was the fact that the 
multivalent presentation of ferrocene–mannose conjugates led to a remarkable enhancement of the 
protein sensing properties due to the multivalent glycoside effect and the multielectron exchange as 
a result of the multiple ferrocene units [36,38]. In addition, the electroactive mannosylated gold 
nanoparticles complemented their redox sensing abilities with the optical sensing abilities that derive 
from their plasmonic properties. In this paper, we use our approach to develop multivalent 
electrochemical probes with high Gal-3 sensing abilities. Since many lectins are oligomeric, a very 
successful strategy to obtain high-affinity ligands is the design of multivalent compounds. 
Nevertheless, Gal-3 is mainly present in solution in a monomeric form in rapid equilibrium with a 
small percentage of protein oligomer [40]. The Gal-3 structure comprises, in addition to the 
carbohydrate recognition domain (CRD), an N-terminal, and collagen-like domains that have 
demonstrated to be important for the formation of Gal-3 oligomers, though CRD is also claimed to 
be involved in inducing aggregation [4,40–42]. For example, the specific interaction of Gal-3 with 
multivalent carbohydrates induces the formation of cross-linked complexes involving Gal-3 
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pentamers [40]. In addition, dynamic light scattering (DLS) experiments have shown that lactose-
functionalized poly (amido amine) (PAMAM) dendrimers of generation 2 to 6 induce Gal-3 
aggregation [43]. Moreover, a multivalent effect was reported to arise from the enhanced binding 
affinity of glycoclusters bearing thiodigalactoside derivatives toward Gal-3 [44]. 
Our studies started with the synthesis of electroactive poly (amidoamine) (PAMAM)-based 
dendrimers from generation 0 to 2, as well as gold nanoparticles bearing lactosylferrocenyl moieties 
in the periphery. The binding and sensing abilities of such multivalent systems toward Gal-3 have 
been evaluated by means of isothermal titration calorimetry, UV–vis spectroscopy, and differential 
pulse voltammetry. 
2. Materials and Methods 
2.1. General Methods 
Thin-layer chromatography (TLC) was performed on Merck silica gel 60 F254 aluminum sheets 
and developed by UV–vis light and ethanolic sulfuric acid (5% v/v). Flash column chromatography 
was performed on Merck silica gel (230–400 mesh, ASTM, West Conshohocken, PA, USA). Infrared 
spectra were recorded on a Bruker Alpha FTIR equipped with a Bruker universal ATR sampling 
accessory. 1H and 13C NMR spectra were recorded on Bruker Avance DPX300 and Bruker Avance 500 
Ultrashield spectrometers equipped with QNP 1H/13C/19F/31P and inverse TBI 1H/31P/BB probes, 
respectively. Standard Bruker software was used for acquisition and processing routines. Chemical 
shifts are given in parts per million (ppm) and referenced to internal TMS (δH, δC 0.00). J values are 
given in hertz (Hz). MALDI-TOF mass spectra were recorded on a 4800 Plus AB SCIEX spectrometer 
with 2,5-dihydroxybenzoic acid (DHB) as the matrix. ESI-TOF mass spectra were measured on a 
Waters Xevo Qtof spectrometer. All aqueous procedures used pure water (Milli-Q, 18.2 MΩ cm) 
obtained from a Millipore Milli-Q Plus system. Centrifugal filtrations were carried out on a Digicen 
21R centrifuge using Amicon Millipore 10 kDa MWCO and 3 kDa MWCO centrifugal filters for 
purification and concentration purposes, respectively. Transmission electron microscopy (TEM) 
analyses were carried out on a Carl Zeiss LIBRA 120 PLUS instrument at 120 keV. All reagents were 
purchased from Sigma Aldrich and used without further purification. Compounds 2 [36], 3 [31,32], 
15 [36], and 16 [36] were synthesized as previously reported. Human galectin-3 was expressed and 
purified as previously reported [45]. 
2.2. Synthesis 
2.2.1. 1-(Hydroxymethyl)-1′-({4-[4-O-(β-D-Galactopyranosyl)-β-D-glucopyranosyloxymethyl]-1H-
1,2,3-tria-zol-1-yl} methyl)ferrocene (5) 
CuSO4 (40 mg, 0.183 mmol) and sodium ascorbate (160 mg, 1.003 mmol) were added to a stirred 
solution of compounds 3 (400 mg, 1.476 mmol) and 4 (465 mg, 1.222 mmol) in THF/H2O (24 mL, 1:1) 
under N2. The resulting mixture was stirred at room temperature for 16 h and then −10% aqueous 
NH3 was added (20 mL). The resulting solution was filtered through silica gel. After that, the solvent 
was evaporated to dryness at reduced pressure avoiding heating over 40 °C. The crude was purified 
by column chromatography on silica gel (EtOAc/MeOH, 2:1) to obtain compound 5 (790 mg, 1.213 
mmol, 99 %) as a yellow solid. IR (KBr, cm−1) 3373, 2925, 2882, 1665, 1401, 1380, 1331, 1236, 1156, 1116, 
1051, 921, 893, 511, 486; 1H NMR (300 MHz; CD3OD) 7.97 (s, 1H, H-5-C2HN3), 5.22 (s, 2H, CH2N3), 
4.96 (d, 1H, 2J = 12.4 Hz, CHO), 4.82 (d, 1H, 2J = 12.4 Hz, CHO), 4.44 (d, 1H, 3J1,2 = 7.6 Hz, H-1), 
4.41−4.36 (m, 3H, H-1′, CpCH2OH), 4.34 (t, 2H, 3J = 1.7 Hz, HCp), 4.28 (t, 2H, 3J = 1.7 Hz, HCp), 4.23 (t, 
2H, 3J = 1.7 Hz, HCp), 4.21 (t, 2H, 3J = 1.7 Hz, HCp), 3.95 (d, 1H, 2J6,6′ = 11.4 Hz, H-6), 3.91−3.83 (m, 2H, 
H-6, 4′), 3.82−3.67 (m, 3H, H-6′, 6′, 5′), 3.66−3.51 (m, 3H, H-4, 3, 2′), 3.50−3.43 (m, 1H, H-3′), 3.40−3.37 
(m, 1H, H-5), 3.32−3.27 (m, 1H, H-2); 13C NMR (75 MHz; CD3OD) 145.5 (C-4-C2HN3), 124.9 (C-5-
C2HN3), 105.1 (C-1′), 103.3 (C-1), 89.2 (CCp), 83.3 (CCp), 80.6 (C-4), 77.0 (C-5′), 76.5 (C-5), 76.2 (C-3), 74.7 
(C-3′), 74.6 (C-2), 72.5 (C-2′), 70.5 (CCp), 70.4 (CCp), 70.3 (CCp), 70.2 (C-4′), 70.1 (CCp), 63.0 (CH2O), 62.5 
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(C-6′), 61.9 (C-6), 60.9 (CH2OH), 50.9 (CH2N3); m/z (HRESI-TOF): Calc. for C27H37FeN3O12 651.1727. 
Found: 652.1215 [M + H]+, 673.1620 [M + Na]+. 
2.2.2. 1-(Azidomethyl)-1′-({4-[4-O-(β-D-galactopyranosyl)-β-D-glucopyranosyloxymethyl]-1H-1,2,3-
triazol-1-yl}methyl)ferrocene (1) 
Compound 5 (650 mg, 0.998 mmol) was dissolved in an aqueous solution of NaN3 (1% w/v) 
acidified with concentrated HCl until pH 1 (−0.5% HCl). The resulting mixture was stirred at room 
temperature for 2 h. Then, it was neutralized with aqueous NaOH until pH 8 and lyophilized. The 
crude was purified by column chromatography on silica gel (EtOAc/MeOH, 2:1) to obtain compound 
1 (607 mg, 0.898 mmol, 90%) as a yellow solid. IR (KBr, cm−1) 3373, 2924, 2885, 2099, 1816, 1645, 1378, 
1328, 1259, 1238, 1225, 1156, 1116, 1058, 893, 834, 790, 705, 640, 507, 488; 1H NMR (300 MHz; CD3OD) 
8.03 (s, 1H, H-5-C2HN3), 5.38 (s, 2H, CH2N3), 4.97 (d, 1H, 2J = 12.4 Hz, CHO), 4.79 (d, 1H, 2J = 12.4 Hz, 
CHO), 4.46 (d, 1H, 3J1,2 = 6.9 Hz, H-1), 4.43−4.37 (m, 3H, H-1′, HCp), 4.32 (t, 2H, 3J = 1.6 Hz, HCp), 
4.31−4.25 (m, 4H, HCps), 4.18 (s, 2H, CH2N3), 4.12−3.72 (m, 5H, H-4′, 6, 6′), 3.70−3.46 (m, 6H, H-2, 3, 3′, 
4, 5, 5’) 3.39−3.28 (m, 1H, H-2, CHD2OD); 13C NMR (75 MHz; CD3OD) 145.4 (C-4-C2HN3), 124.9 (C-5-
C2HN3), 105.1 (C-1′), 103.2 (C-1), 84.4 (CCp), 83.7 (CCp), 80.6 (C-4), 77.0 (C-5′), 76.5 (C-5), 76.0 (C-3), 74.6 
(C-2, 3′), 72.4 (C-2′), 70.8 (CCp), 70.7 (CCps), 70.6 (CCp), 70.3 (C-4′), 63.0 (CH2O), 62.5 (C-6′), 61.7 (C-6), 
51.49 (CH2–C2HN3), 50.8 (CH2N3); m/z (HRESI-TOF): Calc. for C27H36FeN6O11 676.1791. Found: 
652.1377 [M − N2]+, 699.1388 [M + Na]+. 
2.2.3. General Procedure for the Synthesis of Alkyne-Terminated PAMAM Dendrimers 9–11 
Commercially available 20 wt % solutions of amine-terminated PAMAM dendrimers 6–8 in 
methanol were mixed with an equal volume of a solution of CH2Cl2 containing pent-4-ynoic 
anhydride (3 eq. per amino group). The resulting mixture was stirred at room temperature for 3 days. 
Diethyl ether was added until a white precipitate appeared. The solid was filtered off, rigorously 
washed with plenty of diethyl, and used in the next step without further purification. 
G0-PAMAM-(COCH2CH2C≡CH)4 (9) 
Starting from a 20 wt % solution of 6 (85 µL, 0.028 mmol) in methanol, the procedure yielded 9 as 
a white solid (19 mg, 0.023 mmol, 81%). IR (KBr, cm−1): 3288, 3085, 2941, 2835, 1635, 1552, 1442, 1374, 
1298, 1272, 1240, 1126, 1099, 1016, 960, 885, 731, 687, 639; 1H NMR (300 MHz, DMSO-d6): 7.94 (bs, 8H, 
NH), 3.07 (bs, 16H, CH2NHCO), 2.76 (t, 4H, 4J = 2.5 Hz, HC≡C), 2.63 (t, 8H, 3J = 6.8 Hz, CH2N), 2.42 (bs, 
4H, CH2N), 2.38−2.31 (m, 8H, CH2C≡CH), 2.29−2.22 (m, 8H, CH2CO), 2.31 (t, 8H, 3J = 6.8 Hz, CH2CO); 
13C NMR (75 MHz, DMSO-d6): 171.5 (CO), 170.4 (CO), 83.7 (C≡CH), 71.3 (C≡CH), 50.9 (CH2N), 49.6 
(CH2N), 38.4 (CH2NHCO), 38.3 (CH2NHCO), 34.2 (CH2CO), 33.2 (CH2CO), 14.2 (CH2C≡CH); m/z (ESI-
TOF): Calc. for C42H64N10O8 836.5. Found: 841.5 [M + 5H]+. 
G1-PAMAM-(COCH2CH2C≡CH)8 (10) 
Starting from a 20 wt % solution of 7 (204 µL, 0.023 mmol) in methanol, the procedure yielded 10 
as a white solid (37 mg, 0.018 mmol, 78%). IR (KBr, cm−1): 3279, 3081, 2936, 2835, 2117, 1635, 1537, 1430, 
1362, 1234, 1164, 1125, 1037, 644; 1H NMR (300 MHz, DMSO-d6): 8.21−7.65 (bs, 20H, NH), 3.08 (bs, 40H, 
CH2NHCO), 2.74 (bs, 8H, HC≡C), 2.64 (bs, 24H, CH2N), 2.45−2.14 (m, 68H, CH2N, CH2C ≡ CH, CH2CO); 
13C NMR (75 MHz, DMSO-d6): 172.0 (CO), 170.9 (CO), 84.1 (C≡C), 71.7 (C≡CH), 52.5 (CH2N), 49.9 
(CH2N), 38.8 (CH2NHCO), 38.7 (CH2NHCO), 37.3 (CH2NHCO), 34.9 (CH2CO), 34.6 (CH2CO), 33.6 
(CH2CO), 14.6 (CH2C≡CH); m/z (ESI-TOF): Calc. for C102H160N26O20 2070.2. Found: 2071.2 [M + H]+. 
G2-PAMAM-(COCH2CH2C≡CH)16 (11) 
Starting from a 20 wt % solution of 8 (221 µL, 0.012 mmol) in methanol, the procedure yielded 11 
as a white solid (43 mg, 0.009 mmol, 79%). IR (KBr, cm−1): 3286, 3084, 2940, 2835, 1633, 1540, 1432, 1368, 
1238, 1167, 1125, 1023, 638; 1H NMR (300 MHz, DMSO-d6): 8.39−7.58 (bs, 44H, NH), 3.08 (bs, 88H, 
CH2NHCO), 2.80−2.59 (bs, 72H, HC≡C, CH2N), 2.46−2.04 (m, 148H, CH2N, CH2 ≡CH, CH2CO); 13C NMR 
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(75 MHz, DMSO-d6): 172.0 (CO), 171.7 (CO), 170.9 (CO), 84.1 (C≡CH), 71.7 (C≡CH), 52.5 (CH2N), 49.9 
(CH2N), 38.8 (CH2NHCO), 38.7 (CH2NHCO), 37.3 (CH2NHCO), 34.6 (CH2CO), 33.6 (CH2CO), 14.6 
(CH2C≡CH); m/z (ESI-TOF): Calc. for C222H353N58O44 4536.7157. Found: 4538.7 [M + 4H]+. 
2.2.4. General Procedure for the Synthesis of Electroactive Lactosylated PAMAM Dendrimers 12–14 
The alkyne-terminated PAMAM dendrimers (9–11) and 1 (1.5 eq. per alkyne group) were 
dissolved in THF/H2O 1:1 (0.04 mL per mg of 5) under N2 atmosphere. Then, CuSO4 (0.2 eq. per alkyne 
group) and sodium ascorbate (0.4 eq. per alkyne group) were added to the solution in this order. The 
resulting mixture was stirred at room temperature for 20 h. After that, THF was evaporated under 
vacuum without heating over 40 °C. The resulting solution was diluted until −10 mL with 5% aqueous 
NH3 and the product was isolated by repetitive centrifugal filtration (3 kDa cut-off, 10× dilution) with 
5 consecutive concentration and re-dissolution steps. The final solution was lyophilized to obtain the 
corresponding electroactive lactosylated PAMAM dendrimer as a yellow solid. 
G0-PAMAM-(COCH2CH2TACH2FcCH2TACH2Lac)4 (12) 
Starting from 9 (21 mg, 0.025 mmol) in methanol, the procedure yielded 12 as a yellow solid (64 
mg, 0.018 mmol, 72%). IR (KBr, cm−1): 3412, 2930, 1646, 1553, 1435, 1383, 1338, 1237, 1126, 1058, 815, 
712, 623, 508, 493; 1H NMR (300 MHz, DMSO-d6): 8.06 (s, 4H, H5-C2HN3), 8.00−7.85 (m, 8H, NH), 7.76 
(s, 4H, H5′-C2HN3), 5.32 (s, 8H, CH2N3), 5.27 (s, 8H, CH2N3), 5.20−5.05 (m, 8H, OHs), 4.83 (d, 4H, 2J = 
12.4 Hz, CHO), 4.82−4.76 (m, 8H, OHs), 4.73−4.60 (m, 12H, OHs), 4.61 (d, 4H, 2J = 12.4 Hz, CHO), 
4.39−4.29 (m, 20H, HCp, H-1′), 4.23−4.16 (m, 20H, HCp, H-1), 3.80 (dd, 4H, 2J6’,6 = 11.2 Hz, 3J6’,5 = 11.2 Hz, 
H-6′), 3.65−3.40 (m, 16H, H-4′,5, 5′,6), 3.39−3.18 (m, H-2, 2′, 3, 3′, 4, HDO), 3.05 (bs, 16H, CH2NHCO), 
2.81 (t, 8H, 3J = 7.6 Hz, CH2-C2HN3), 2.63 (bs, 8H, CH2N), 2.45–2.33 (m, 12H, CH2N, CH2CO), 2.19 (bs, 
8H, CH2CO); 13C NMR (75 MHz, DMSO-d6): 171.5 (CO), 171.3 (CO), 146.0 (C4-C2HN3), 143.7 (C4-
C2HN3), 123.7 (C5-C2HN3), 121.4 (C5-C2HN3), 103.8 (C-1’), 101.8 (C-1), 83.2 (CCp), 82.9 (CCp), 80.7 (C-
4), 75.5 (C-5’), 74.9 (C-3, 5), 73.2 (C-2′), 73.0 (C-2), 70.5 (C-3′), 69.6 (CCp), 69.5 (CCp), 69.3 (CCp), 69.2 (CCp), 
68.1 (C-4′), 61.7 (CH2O), 60.5 (C-6), 60.4 (C-6′), 50.8 (CH2N), 49.6(CH2N), 48.6 (CH2N3), 48.5 (CH2N3), 
38.3 (CH2NHCO), 34.9 (CH2CO), 33.2 (CH2CO), 21.2 (CH2-C2HN3); m/z (HRESI-TOF): Calc. for 
C150H208Fe4N34O52 3542.2108. Found: 1772.1643 [M + 2H]2+, 1181.3887 [M + 3H]3+, 886.2606 [M + 4H]+. 
Number of expected lactose units per dendrimer: 4. Found by sulfuric acid–phenol assays: 4.10 ± 0.21 
(see the Supplementary Materials). 
G1-PAMAM-(COCH2CH2TACH2FcCH2TACH2Lac)8 (13) 
Starting from 10 (60 mg, 0.029 mmol) in methanol, the procedure yielded 13 as a yellow solid (155 
mg, 0.021 mmol, 73%). IR (KBr, cm−1): 3363, 2956, 2922, 2852, 1731, 1653, 1553, 1461, 1435, 1378, 1339, 
1237, 1129, 1057, 973, 816, 684, 642, 510, 489; 1H NMR (300 MHz, DMSO-d6): 8.06 (s, 8H, H5-C2HN3), 
8.00–7.81 (m, 20H, NH), 7.76 (s, 8H, H5′-C2HN3), 5.31 (s, 16H, CH2N3), 5.27 (s, 16H, CH2N3), 5.19 (bs, 8H, 
OHs), 5.11 (bs, 8H, OHs), 4.89−4.76 (m, 16H, CHO, OH), 4.74−4.48 (m, 40H, CHO, OHs), 4.39−4.27 (m, 
40H, HCp, H-1′), 4.26−4.15 (m, 40H, HCp, H-1), 3.84−3.74 (m, 8H, H-6′), 3.65−3.34 (m, 64H, H-4′, 5, 5′, 6, 2, 
2′, 3, 3′, 4), 3.06 (bs, 40H, CH2NHCO), 2.81 (t, 16H, 3J = 7.0 Hz, CH2-C2HN3), 2.64 (bs, 24H, CH2N), 
2.45−2.33 (m, 28H, CH2N, CH2CO), 2.18 (bs, 24H, CH2CO); 13C NMR (75 MHz, DMSO-d6): 171.6 (CO), 
171.4 (CO), 171.3 (CO), 146.0 (C4-C2HN3), 143.7 (C4-C2HN3), 123.7 (C5-C2HN3), 121.4 (C5-C2HN3), 103.9 
(C-1’), 101.9 (C-1), 83.1 (CCp), 82.8 (CCp), 80.7 (C-4), 75.5 (C-5′), 74.9 (C-3, 5), 73.2 (C-2′), 73.0 (C-2), 70.5 (C-
3’), 69.6 (CCps), 69.3 (CCp), 69.2 (CCp), 68.1 (C-4′), 61.7 (CH2O), 60.5 (C-6), 60.4 (C-6′), 52.2 (CH2N), 
49.5(CH2N), 48.6 (CH2N3), 48.5 (CH2N3), 38.4 (CH2NHCO), 38.3 (CH2NHCO), 36.9 (CH2NHCO), 34.9 
(CH2CO), 33.2 (CH2CO), 21.2 (CH2-C2HN3); m/z (MALDI-TOF): Calc. for C318H448Fe8N74O108 7481.7 (EM); 
Found: 7481.3 [M]+. Number of expected lactose units per dendrimer: 8. Found by sulfuric acid–phenol 
assays: 7.97 ± 0.23 (see Supplementary Materials). 
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G2-PAMAM-(COCH2CH2TACH2FcCH2TACH2Lac)16 (14) 
Starting from 11 (40 mg, 0.009 mmol) in methanol, the procedure yielded 14 as a yellow solid 
(101 mg, 0.007 mmol, 73%). IR (KBr, cm−1): 3415, 2931, 1643, 1552, 1436, 1373, 1337, 1327, 1128, 1056, 
813, 716, 682, 591, 493; 1H NMR (300 MHz, DMSO-d6): 8.06 (s, 16H, H5-C2HN3), 8.00−7.77 (m, 44H, 
NH), 7.76 (s, 16H, H5′-C2HN3), 5.31 (s, 32H, CH2N3), 5.27 (s, 32H, CH2N3), 5.20 (bs, 16H, OHs), 5.11 
(bs, 16H, OHs), 4.89−4.75 (m, 32H, CHO, OH), 4.74−4.47 (m, 80H, CHO, OHs), 4.39−4.28 (m, 80H, HCp, 
H-1′), 4.26−4.10 (m, 80H, HCp, H-1), 3.87−3.74 (m, 16H, H-6’), 3.70−3.41 (m, 64H, H-4′,5, 5′,6), 3.40−3.21 
(m, H-2, 2′, 3, 3′, 4, HDO), 3.06 (bs, 84H, CH2NHCO), 2.81 (t, 32H, 3J = 7.3 Hz, CH2-C2HN3), 2.65 (bs, 
56H, CH2N), 2.48−2.31 (m, 60H, CH2N, CH2CO), 2.18 (bs, 56H, CH2CO); 13C NMR (75 MHz, DMSO-
d6): 171.6 (CO), 171.4 (CO), 171.3 (CO), 146.0 (C4-C2HN3), 143.7 (C4-C2HN3), 123.7 (C5-C2HN3), 121.4 
(C5-C2HN3), 103.9 (C-1’), 101.9 (C-1), 83.1 (CCp), 82.9 (CCp), 80.7 (C-4), 75.5 (C-5′), 74.9 (C-3, 5), 73.2 (C-
2’), 73.0 (C-2), 70.5 (C-3′), 69.7 (CCp), 69.6 (CCp), 69.4 (CCp), 69.3 (CCp), 68.2 (C-4′), 61.7 (CH2O), 60.5 (C-
6), 60.4 (C-6′), 52.1 (CH2N), 49.5(CH2N), 48.7 (CH2N3), 48.5 (CH2N3), 38.4 (CH2NHCO), 38.3 
(CH2NHCO), 36.9 (CH2NHCO), 34.9 (CH2CO), 33.2 (CH2CO), 21.2 (CH2-C2HN3); m/z (ESI-TOF): Calc. 
for C654H928Fe16N154O220 15361 Found: 15361 [M]+. Number of expected lactose units per dendrimer: 16. 
Found by sulfuric acid–phenol assays: 16.35 ± 1.11 (see Supplementary Materials). 
2.2.5. Bis [2 3-(3-{1-[1′-({4-[4-O-(β-D-galactopyranosyl)-β-D-glucopyranosyloxymethyl]-1H-1,2,3-
triazol-1-yl}methyl)ferrocenylmethyl]-1H-1,2,3-triazol-4-yl}propanoylamino)-12,15,18,21-
tetraoxatricosanyl] disulfide (17) 
CuSO4 (7 mg, 0.032 mmol) and sodium ascorbate (10 mg, 0.063 mmol) were added to a stirred 
solution of compounds 16 (70 mg, 0.076 mmol) and 1 (113 mg, 0.167 mmol) in THF/H2O (6 mL, 1:1) 
under N2. The resulting mixture was stirred at room temperature overnight and then the solvent was 
evaporated to dryness at reduced pressure. The crude was purified by column chromatography on 
silica gel (CH3CN/H2O/NH3(aq.) 30%, 8:2:1 → 10:4) to obtain compound 17 (164 mg, 0.072 mmol, 95%) 
as a yellow solid. IR (KBr, cm−1): 3390, 2931, 1635, 1237, 1167, 1126, 1097, 1079, 1061, 1025, 840, 815, 
583, 501 cm−1; 1H NMR (300 MHz, DMSO-d6): 8.08 (s, 2H, H-5-C2HN3), 7.92 (bs, 2H, NHs), 7.75 (s, 2H, 
H-5-C2HN3), 5.31 (s, 4H, CH2-C2HN3), 5.26 (s, 4H, CH2-C2HN3), 4.82 (d, 2J = 12.0 Hz, 2H, CHO), 4.60 
(d, 2J = 12.0 Hz, 2H, CHO), 4.40−4.27 (m, 6H, HCp, H-1), 4.24−4.14 (m, 6H, HCp, H-1′), 3.86−3.74 (m, 6H, 
H-2, 6), 3.67−3.13 (m, H-2′, 3, 3′, 4, 4′, 5,5′,6′, CH2OEG, CH2NHCO, OCH2(CH2)10, HDO), 3.01 (t, 3J = 7.5 
Hz, 4H, CH2CONH), 2.80 (t, 3J = 7.0 Hz, 4H, CH2-C2HN3), 2.67 (t, 3J = 7.1 Hz, 4H, CH2S), 1.67−1.53 (m, 
4H, (CH2)9), 1.52−1.39 (m, 4H, (CH2)9), 1.38−1.12 (m, 28H, (CH2)9); 13C NMR (75 MHz, DMSO-d6): 171.6 
(CO), 146.0 (C4-C2HN3), 143.7 (C4-C2HN3), 123.7 (C5-C2HN3), 121.4 (C5-C2HN3), 103.8 (C-1′), 101.8 (C-
1), 83.2 (CCp), 82.9 (CCp), 80.7 (C-4), 75.5 (C-5′), 74.9 (C-3, 5), 73.2 (C-2′), 73.1 (C-2), 70.5 (C-3′), 70.3 
(CH2OEG), 69.8 (CH2OEG), 69.7 (CH2OEG), 69.6 (CCp), 69.5 (CCp), 69.4 (CH2OEG), 69.3 (CCp), 69.2 (CCp), 
69.1 (CH2OEG), 68.1 (C-4′), 61.7 (CH2O), 60.5 (C-6), 60.4 (C-6′), 48.6 (CH2N3), 48.4 (CH2N3), 38.5 
(CH2NHCO), 37.9 (CH2S), 34.7 (CH2CONH), 29.2, 29.0, 28.9, 28.5, 25.6 [(CH2)9], 21.2 (CH2-C2HN3); m/z 
(ESI-TOF): Calc. for C102H160Fe2N14O32S2 2269.9497 Found: 2270.5857 [M + H]+. 
2.2.6. Synthesis of Citrate-Stabilized AuNPs 
Citrate-stabilized AuNPs were prepared according to a modification [46] of the Turkevich 
protocol [47]. Briefly, a degassed solution of sodium citrate (228 mg, 0.775 mmol) in Milli-Q water (20 
mL) at 55 °C was added to a refluxing degassed solution of HAuCl4·3H2O (79 mg, 0.201 mmol) in 
Milli-Q water (200 mL) under vigorous stirring. The mixture was refluxed for 30 min and cooled to 
room temperature before being filtered through a Sartorius Minisart 0.2 µm filter to provide citrate-
stabilized AuNPs of 12.1 ± 1.0 nm of average diameter in a concentration of 16 nM, as determined by 
UV–vis spectroscopy [48] and TEM. The citrate-stabilized AuNPs solution was washed with 1 mM 
NaOH [36,49] by repetitive centrifugal filtration (10 kDa cut-off, 10× dilution) with three consecutive 
concentration and re-dissolution steps to obtain 16 nM AuNPs solution in 1 mM NaOH with an 
average size of 12.1 ± 1.2 nm as determined by TEM. 
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2.2.7. Preparation of AuNP@Fc-Lac 
A 2.5 mM solution of disulfide 17 in methanol (2 mL) was added to a stirred solution of 16 nM 
citrate-stabilized AuNPs in 1 mM NaOH (10 mL) and the resulting solution was stirred for 24 h. After 
that, THF (10 mL) was added and the resulting suspension was precipitated by centrifugation at 4000 
rpm for 20 min. The supernatant was removed and the functionalized AuNPs were re-dissolved in 
H2O (10 mL). THF (10 mL) was added and the resulting suspension was precipitated again by 
centrifugation at 4000 rpm for 20 min. The process was repeated 3 times. After that, the functionalized 
AuNPs were dissolved in 10 mm phosphate buffer (pH 7.2) and dialyzed by centrifugal filtration (10 
x dilution, Millipore Amicon Centriplus 10 kDa). The process was repeated 4 times to obtain a final 
solution of 20 nm AuNP@Fc-Lac (8 mL) in 10 mm phosphate buffer (pH 7.2). Average diameter of 
the gold core = 12.2 ± 1.1 nm (from TEM analysis). Number of ligands/AuNP = 1659 ± 94 (from 
elemental gold-to-iron ratio as determined by ICP-OES). Concentrations were determined by 
transmission electron microscopy (TEM) and UV–visible spectroscopy [48]. 
2.3. UV–Visible Experiments 
UV–visible measurements were performed using Jasco V-530 spectrophotometer at room 
temperature using a 1 cm path length. For protein assays, aqueous dispersions of AuNP@Fc-Lac (2 
nM) in phosphate buffer 10 mM at pH 7.2 with 20 mM NaCl were treated with a final concentration 
of 10.0 µM of Gal-3 or bovine serum albumin. 
2.4. Voltammetric Experiments 
Electrochemical measurements were carried out in sonicated, nitrogen-purged aqueous (Milli-
Q 18.2 MΩ cm) solution with a micro-Autolab type III connected to a personal computer running Eco 
Chimie B. V. GPES 4.9 software. The electrodes were carefully cleaned before each experiment. The 
glassy carbon disk working electrode (Ø 2 mm, effective area 0.038 ± 0.006 cm2) was immersed in a 
0.1 M HNO3 solution for 5 min and polished with a basic Al2O3 water slurry. The platinum sheet 
counter electrode (6 × 4 mm, effective area 0.410 ± 0.003 cm2) was immersed in a 50% v/v H2SO4 
solution for 5 min. Both electrodes were then sonicated in a 1:1:1 H2O/MeOH/CH3CN mixture for 5 
min prior to use. The effective area of the electrodes was determined as previously reported [39]. An 
Ag/AgCl (3 M KCl) electrode was used as a reference. Solutions of conjugate 18 (Figure 1) and 
dendrimers 12–14 (50 µM for 18, 25 µM for 12, 12.5 µM for 13 and 6.25 µM for 14) and increasing 
amounts of Gal-3 varying from 0 to 45 µM were prepared in 10 mM phosphate buffer at pH 7.2 with 
20 mM NaCl and incubated for 10 min at room temperature. Before each measurement with 
AuNP@Fc-Lac, the glassy carbon electrode was modified by incubation in solutions of AuNP@Fc-Lac 
(20 nM) in 10 mM phosphate buffer at pH 7.2 with 20 mM NaCl for 1 h at room temperature and then 
washed with plenty of H2O. After that, it was allowed to equilibrate for 10 min in solutions of 
different concentrations of Gal-3 ranging from 0 to 500 nM. Nitrogen was bubbled through the 
solutions for 3 min before each measurement. Differential pulse voltammetry experiments were 
measured with a scan rate of 5 mVs−1, a step potential of 20 mV, a modulation amplitude of 50 mV, a 
modulation time of 0.05 s, and an interval time of 2 s between 0 and 1 V for AuNP@Fc-Lac, 0 and 0.8 
V for dendrimers 12–14, and 0 and 0.7 for 18. 
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Figure 1. Chemical structure of compound 18. 
2.5. Isothermal Titration Calorimetry Measurements 
Calorimetric experiments were conducted using either an MCS or an ultrasensitive VP-ITC 
(Microcal Inc., Northampton, MA, USA). The preparation of samples and isothermal titration 
calorimetry (ITC) experiments were carried out as previously described elsewhere [50]. Titrations 
were routinely performed in a 20 mM phosphate buffer at pH 7.2 with 150 mM NaCl at 25 °C. During 
titrations, the reaction mixture was continuously stirred at 370 rpm and the reference cell was filled 
with Milli-Q water. Blank titrations of ligand into buffer were also performed to correct the heat 
generated by dilution and mixing. The amount of heat produced per injection was calculated by 
integration of the individual peaks by the Origin software provided with the instrument. An equal 
and independent site model was used to fit the experimental data. This model provided the binding 
constant, the enthalpy change, and the number of binding sites (n) along with the corresponding 
standard deviations. The changes in the standard free energy ΔG0 and entropy ΔS0 were determined 
as ΔG0 = −RTlnK and TΔS0 = ΔH − ΔG0 (assuming that ΔH = ΔH0). 
3. Results and Discussion 
3.1. Synthesis 
To generate multivalent presentations of ferrocene–lactose (Fc-Lac) conjugates, we chose 
PAMAM dendrimers and Au nanoparticles (AuNPs) as scaffolds for the display of the conjugates. 
We started our studies with the preparation of building block 1, consisting of an azide-functionalized 
lactose–ferrocene conjugate, which is ready for further conjugation or direct coupling using azide-
alkyne cycloaddition (AAC). This building block 1 was key for the convenient synthesis of the 
multivalent electrochemical probes. Commercially available 1,1′-bis(hydroxymethyl)ferrocene 2 was 
regioselectively transformed, in one step, into mono-azidoferrocene 3 in high a yield (Scheme 1) [36]. 
Cu(I)-catalyzed AAC of ferrocene derivative 3 with propargyl β-D-lactoside 4 [45] afforded Fc-Lac 
conjugate 5 in an almost quantitative yield. The treatment of such conjugate with sodium azide in 
aqueous HCl allowed the introduction of a new azido group in a high yield. The resulting azido-
functionalized Fc-Lac 1 was then used for an additional Cu (I)-catalyzed AAC with alkyne-
terminated PAMAM dendrimers 9–11 to obtain Fc-Lac dendrimers 12–14 in 78–81% yields. Similarly, 
azido-functionalized Fc-Lac 1 reacted with alkynylated disulfide 16 [36] to obtain Fc-Lac disulfide 17 
in a 95% yield. Alkyne-terminated PAMAM dendrimers 9–11 and disulfide 16 were prepared via the 
reaction of the corresponding amino derivatives 6–8 and 15 with pent-4-ynoic anhydride [51] 
(Scheme 1). 




Scheme 1. (a) NaN3, HCl., EtOAc/H2O, room temperature, 45 min; (b) CuSO4, sodium ascorbate, 
THF/H2O, room temperature, overnight; (c) NaN3, HCl(aq), room temperature, 2 h; (d) pent-4-ynoic 
anhydride, CH2Cl2/MeOH, room temperature, overnight. 
The 1H- and 13C-NMR analysis of Fc-Lac dendrimers 12–14 and disulfide 17 evidenced the 
presence of two chemically different 1,2,3-triazole rings. The 1H NMR spectra revealed two singlets 
at 8.06–8.08 and 7.75–7.76 ppm, corresponding to the 1,2,3-triazole methine protons. The 13C NMR 
spectra displayed four signals: two at 146.0 and 143.7 ppm and two at 123.7 and 121.4, corresponding 
to the triazole C-4 and C-5 atoms, respectively. The 13C NMR spectra also showed two signals at 
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103.8–103.9 and 101.8–101.9 ppm corresponding to the anomeric carbons of the β-D-galacto- and β-D-
glucopyranoside units of the β-D-lactoside moieties. In addition, the protons of the methylenes 
linking the triazole moieties to the metallocene units were clearly observable in the 1H NMR spectra 
as two singlets at 5.32–5.32 and 5.27–5.26 ppm. The ESI- and MALDI-TOF spectra confirmed the 
molecular weight of Fc-Lac dendrimers 12–14 and disulfide 17. For the Fc-Lac dendrimers, the 
number of carbohydrate units per dendrimer was determined by means of sulfuric acid–phenol 
assays to be 4.1 ± 0.2, 8.0 ± 0.2 and 16.4 ± 1.1 for 12, 13, and 14, respectively (see Supplementary 
Materials) [38]. 
Fc-Lac disulfide 17 was employed to functionalize citrated-capped AuNPs. Citrate-capped gold 
nanoparticles were prepared according to a modification [46] of the Turkevich protocol [47], as 
reported elsewhere [36,45,52]. Functionalized AuNPs were prepared by mixing an excess of Fc-Lac 
disulfide 17 with 12 nm citrate-capped AuNPs in 1 mM NaOH for 24 h at room temperature. After 
removing the unreacted disulfide 17, the UV/Vis spectra of the resulting Fc-Lac-functionalized 
AuNPs (AuNPs@Fc-Lac) revealed a bathochromic shift of 8 nm of the SPR band. Redshift is a distinct 
indication of sulfur anchoring and has been attributed to changes in the electronic environment on 
the surface of AuNPs [36,45,53,54]. No broadening in the SPR band was observed, which excluded 
ligand-induced AuNPs aggregation. The average diameter (12.2 nm) of the nanoparticle gold cores 
was unaltered after functionalization, as determined by TEM analyses (see Supplementary Materials 
for details). The average number of ligands per nanoparticle was estimated to be 1765 ± 32 based on 
the elemental gold-to-iron ratio obtained by inductively coupled plasma optical emission 
spectroscopy (ICP-OES) in combination with the TEM data (see Supplementary Materials) 
3.2. Electrochemical Characterization 
The differential pulse voltammograms of the Fc-Lac dendrimers 12–14 and mono-Fc-Lac 
conjugate 18 [32] in 10 mM phosphate buffer at pH 7.2 with 20 mM NaCl as the supporting electrolyte 
are shown in Figure 2. The voltammograms of multivalent compounds 12–14 showed only one peak 
potential (Ep) (+0.456, +0.461, and +0.482 V, respectively) for the oxidation of the ferrocene moieties 
(Table 1), which is consistent with the apparent equivalence of all ferrocene residues displayed by 
each glycodendrimer at the timescale of the electrochemical measurement [38,55]. Contrary to the 
previously investigated mannosylferrocenyl PAMAM dendrimers [38], in which the observed 
oxidation potential was independent of the dendrimer generation, we observed a slight shift to a 
more positive Ep value of −0.026 V when going from dendrimer generation G0 to G2. This behavior 
may be related to the lesser polar microenvironment around the ferrocene residue with an increase 
of dendrimer generation. Moving from a monosaccharide to a disaccharide may lead to a more 
shielded ferrocene from solvent interactions and will, therefore, make the ferrocene moiety more 
difficult to oxidize. This shielding effect would be more effective in dendrimer 14 with the highest 
generation. Another variation from the previously reported glycoferrocenyl dendrimer is the 
substitution of an electron-withdrawing amide group directly attached to the ferrocenyl group by an 
electron-donating methyltriazole group, which led to lower Ep values than those reported (+0.560 V). 
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Figure 2. Differential pulse voltammograms for 12 (25 µM, green), 13 (12.5 µM, red), 14 (6.25 µM, 
blue), and 18 (50 µM, orange) in 10 mM phosphate buffer at pH 7.2 and 25 °C with 20 mM NaCl as 
the supporting electrolyte. 
Table 1. Oxidation potential (Ep) and current intensity (Ip) of differential pulse voltammetry (DPV) 
peaks for 18, and 12–14 in 10 mM phosphate buffer at pH 7.2 and 25 °C with 20 mM NaCl. 





18 50 50 +0.292 0.62 
12 25 100 +0.456 1.21 
13 12.5 100 +0.461 1.39 
14 6.25 100 +0.482 2.26 
 
Interestingly, the DPV peak current (Ip) values 0.62, 1.21, 1.39, and 2.26 µA for mono- 18, tetra- 
12, octa- 13, and hexadecamer 14, respectively, increase with the glycodendrimer generation (Table 
1). This trend is the opposite of that observed for the previously reported mannosylferrocenyl 
dendrimer [38]. The Ip value is directly proportional to the concentration and the square of the 
diffusion coefficient of the electroactive species, the number of exchanged electrons, and the electrode 
surface [56]. Hence, for lactosylferrocenyl dendrimers, the increase of the electrochemical signal that 
results from the increased number of exchanged electrons prevails over the expected decrease of the 
peak current due to the slower diffusion of the larger electroactive species. This behavior might be 
due to stronger adsorption of the larger dendrimer onto the electrode, which results in an 
enhancement of the Ip value [55]. 
The electrochemical properties of AuNP@Fc-Lac were also studied by DPV. DPV measurements 
of AuNP@Fc-Lac were carried out on a 20 nM nanoparticle solution in 10 mM phosphate buffer at 
pH 7.2 with 20 mM NaCl, after being incubated for 1 h in the presence of a glassy carbon working 
electrode, an Ag/AgCl (3 M KCl) reference electrode, and a Pt sheet counter electrode. The differential 
pulse voltammogram of AuNP@Fc-Lac showed an oxidation peak with a peak current value of 6.11 
µA at an oxidation potential value of 0.620 V. 
3.3. Binding Abilities Toward Galectin-3 
We investigated the binding abilities of mono- 18, tetra- 12, octa- 13, and hexadeca-Fc-Lac 14 
toward Gal-3, as we envisaged that enhanced Gal-3 binding due the multivalent effect would 
contribute to improved sensing abilities. 
Nanomaterials 2020, 10, 203 12 of 22 
 
Isothermal titration calorimetry (ITC) provided the thermodynamic parameters (K, ΔG0, ΔH, and 
TΔS0) that allow us to characterize how multivalency affects the binding affinities. ITC experiments 
were developed at pH 7.2 in 20 mM phosphate buffer with 150 mM NaCl at 25 °C. The stepwise 
addition of a solution of Fc-Lac 18 and 12–14 into a solution of Gal-3 led to a series of exothermic 
peaks with a decreasing area. Figure 3 shows a representative thermogram for the binding of 13 to 
Gal-3. Calorimetric data were fitted to an equal and independent binding site model facilitating the 
direct determination of the data displayed in Table 2. Globally, the complexation of the Fc-Lac 
derivatives with Gal-3 is enthalpy driven and entropically unfavorable, as the binding is dominated 
by enthalpy contributions (Figure 4). 
 
Figure 3. Representative titration of galectin-3 (Gal-3) (40.58 µM) with compound 13 (0.514 mM) in 20 
mM phosphate buffer at pH 7.2 with 150 mM NaCl at 25 °C. The top panel shows the raw calorimetric 
data for 25 automatic injections, 5 µL each (1 µL for the first) of 13. The area under each peak 
represents the amount of heat released upon binding of the conjugate to the lectin. The smooth solid 
lines (bottom panel) represent the best fit of the experimental data to a model of n equal and 
independent sites. 
Table 2. Thermodynamic parameters for compounds 12–14 and 18 obtained by isothermal titration 
calorimetry in 20 mM phosphate buffer at pH 7.2 with 150 mM NaCl at 25 °C. 
Compound −ΔG0 (kJ∙mol−1) −ΔH (kJ∙mol−1) TΔS0 (kJ∙mol−1) K∙10−4 (M−1) n 
18 21.74 ± 0.11 37.81 ± 3.72 −16.07 ± 3.70 0.66 ± 0.03 1.00 
12 31.48 ± 0.14 194.66 ± 7.30 −163.18 ± 7.25 31.82 ± 2.10 0.19 ± 0.05 
13 32.90 ± 0.06 194.83 ± 2.01 −161.93 ± 1.98 54.82 ± 1.40 0.17 ± 0.01 
14 34.36 ± 0.31 97.02 ± 3.60 −62.66 ± 3.20 103.04 ± 13.0 0.26 ± 0.01 
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Figure 4. Free energy (−ΔG0, black), enthalpy (−ΔH, red), and entropy changes (TΔS0, green) for the 
binding of Fc-Lac dendrimers 12–14 and monovalent glycoconjugate 18 to Gal-3 obtained from 
isothermal titration calorimetry (ITC) experiments in 20 mM phosphate buffer at pH 7.2 with 150 mM 
NaCl at 25 °C. 
As can be seen in Table 2, the K values increase with the number of lactoside residues of the 
dendrimers, from monomer 18 to hexadecamer 14, due to a multivalent effect, with the binding 
affinities of tetramer 12, octamer 13, and hexadecamer 14 being −48-, −83-, and −156-fold higher than 
that for monomer 18. A deeper analysis revealed that binding enthalpy ΔH values rapidly decrease 
(become more favorable) when going from monomer 18 to dendrimer 12, which possesses four 
lactoside residues, where the ΔH value of 12 is −5 times lower than that for 18. However, moving 
from tetramer 12 to octamer 13, a small ΔΔH value of −0.17 kJ mol−1 is observed, which likely means 
that not all the lactoside moieties are involved in the binding. Furthermore, the increase in the 
multivalence to 16 lactoside residues led to an increase of 97.81 kJ mol−1 (less favorable) of the 
enthalpy binding. Nevertheless, these changes in enthalpy binding with an increase in the number of 
lactoside residues are counterbalanced by changes in unfavorable entropic contributions. For 
example, a less favorable enthalpy binding for 16-mer 14, compared to 4-mer 12 and 8-mer 13, is 
compensated with a less unfavorable entropic term than that for the compounds. Thus, a strong 
enthalpy–entropy compensation behavior is observed with a slope slightly greater than unity (Figure 
5), which is typically found in carbohydrate–lectin binding interactions [57,58]. Although the origin 
of this phenomenon remains unclear, such compensatory behavior has been attributed to solvent 
reorganization upon ligand binding, suggesting that the Fc-Lac conjugates follow a similar binding 
mechanism. The n values are lower than unity for all multivalent glycoconjugates (Table 2), as 
expected for the interactions of multivalent carbohydrates with oligomeric lectins [59]. Such behavior 
suggests an increase in the cross-linking between the glycoconjugates and Gal-3, with an increase of 
the number in lactoside residues. However, while Fc-Lac dendrimers 12 and 13 showed n values 
below and relatively close to the theoretically expected values for a tetramer (1/2 = 0.25) and an 
octamer (1/8 = 0.125), Fc-Lac 16-mer 14 showed a value larger than that theoretically expected (1/16 = 
0.063), which indicates that, for this compound, not all of the lactoside residues participate in the 
binding, as noted above. 
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Figure 5. Enthalpy–entropy compensation plot. Plot of the −ΔH versus −TΔS0 for the binding of 
compounds 12–14 and 18 to Gal-3. The plot shows a linear relationship with a slope of 1.05 and a 
correlation coefficient of 0.997. 
It is noteworthy to mention that the binding affinity of Fc-Lac dendrimers, and particularly 
hexadecamer 14, is within the range of magnitude of the potent Gal-3 inhibitors [4,60]. Therefore, 
they can be applied as anti-Gal-3 agent for therapeutic purposes. We tested the binding ability of 
AuNP@Fc-Lac toward Gal-3 by following their UV–vis spectra variations after the addition of the 
lectin. It is well-known that this technique is a very useful tool to demonstrate protein-induced 
aggregation of AuNPs due to the dependence of the surface plasmon resonance (SPR) band on 
interparticle distance [36,61,62]. Thus, upon AuNPs aggregation, coupling interactions between the 
surface plasmon fields of the nanoparticles take place, leading to a change of the local refractive index 
around the nanoparticles, a red shift of the SPR band, and (usually) a broadening that, on occasion, 
results in absorbance decay. 
The treatment of the AuNP@Fc-Lac solution with Gal-3 in a phosphate buffer at pH 7.2 led to a 
red shift of the SPR band along with a progressive decrease of its absorbance (ASPR) with time (Figure 
6). In this experiment, the used solution contained 20 mM NaCl in order to keep a high ionic strength 
and to ensure the stability of the protein and avoid its aggregation. Both the SPR band increase (ΔλSPR) 
and absorbance decrease (ΔASPR) versus when time plots reached a plateau at 90 min. These results 
can be reasoned in terms of the closer special arrangement of AuNPs as a result of the formation of 
cross-linked complexes between AuNP@Fc-Lac and Gal-3. Thus, an increase in size of the aggregates 
with time brings about both a shift and a broadening of the SPR band. Eventually, the complex 
became water-insoluble and precipitated, leading to a decrease in absorbance. This UV–vis behavior 
of the binding interaction of Gal-3 and AuNP@Fc-Lac contrasts with that observed for the AuNP@Lac 
without a ferrocene moiety, which exhibited, in the presence of five times more concentrated Gal-3, 
a negligible change of λSPR and an increase of ASPR during a period of 5 h [45]. Either the presence of 
the ferrocene moiety or the lower Gal-3 concentration at which the experiments were carried out (or 
both) seem to favor faster aggregation upon binding interactions, and allow for an arrangement of 
the AuNPs at more optimal interparticle distances. To test the participation of the lactose moiety in 
the binding, a saturated aqueous solution of lactose was added to the sample containing AuNP@Fc-
Lac and Gal-3 after a period of incubation of 1.5 h. After 15 min, a completed re-dissolution was 
observed and the UV–vis spectrum showed the recovery of the original SPR band, albeit at a lower 
absorbance than the original. Moreover, the UV–vis spectrum of AuNP@Fc-Lac in the presence of 
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bovine serum albumin (BSA) under the same conditions did not show any SPR band shift after a 
period of incubation of 5 h (Figure 6). These results confirm the specificity of the binding interaction 
and the lack of significance of the non-specific interactions. 
  
Figure 6. a) UV–visible spectra of AuNP@Fc-Lac (2 nM) in a phosphate buffer of 10 mM, pH 7.2 with 
20 mM NaCl in the presence of Gal-3 (10 µM) recorded at different times after addition of the lectin 
along with the UV–visible spectrum of this mixture after the addition of an aqueous saturated D-
Lactose solution (dashed blue). b) UV–visible spectra of AuNP@Fc-Lac (2 nM) in phosphate buffer 10 
mM, pH 7.2, in the presence of BSA recorded at different times. Variation of ΔλSPR (c) and absorbance 
at 700 nm (d) over time. 
3.4. Sensing Abilities Toward Gal-3 
Once we had demonstrated the redox properties of PAMAM@Fc-Lac 12–14 and AuNP@Fc-Lac 
and their strong specific binding interactions with Gal-3, we studied their electrochemical sensing 
properties. In order to assess such sensing abilities, we evaluated the extent of the variation of the 
peak current upon the interaction of the electroactive spices with Gal-3. For this assessment, we used 
sensitivity parameters (Ps), which are defined as (Ip0−Ip)/Ip0, where Ip0 and Ip represent the peak 
currents in the absence and in the presence of Gal-3, respectively. The Ps parameter is proportionally 
related to the number of redox units that became incorporated into the low-diffusing cross-linked 
complex upon binding with the lectin. Consequently, this parameter is related to both the stability of 
the complexes (K values) and the number of ferrocene units (valency) participating in the complex. 
In all cases, DPV voltammograms showed a progressive decrease of the Ip values as the Gal-3 
concentration increased, which is indicative of the formation of electroactive Fc-Lac conjugate–Gal-3 
complexes (Figures 7 and 8). As the Ip value is proportional to the square root of the diffusion 
coefficient of the electroactive species, and the Fc-Lac-conjugate–Gal-3 complexes are expected to 








Figure 7. a) Differential pulse voltammograms for compound 13 (12.5 µM) in the presence of 
increasing amounts of Gal-3 (0 µM, red; 3 µM, blue; 15 µM, 45 µM,) in 10 mM phosphate buffer at pH 
7.2 with 20 NaCl. A decrease in the peak current was observed as the Gal-3 concentration increased. 
b) Variation of the peak current intensity (DPV) of compounds 18 (50 µM, rhombs), 12 (25 µM, 
triangles), 13 (12.5 µM, squares), and 14 (6.25 µM, circles) in the presence of increasing amounts of 
Gal-3 (dashed lines represent the exponential fits). 
a) 
b) 
Nanomaterials 2020, 10, 203 17 of 22 
 
 
Figure 8. Differential pulse voltammogram for AuNP@Fc-Lac-modified glassy carbon electrode in the 
presence of increasing amounts of Gal-3 (0 nM, blue; 100 nM, red; 200 nM, green; 300 nM, orange; 500 
nM, purple) in 10 mM phosphate buffer at pH 7.2 with 20 mM NaCl as the supporting electrolyte. 
The PS of the Fc-Lac conjugates is shown in Figure 9. The highest sensitivity to Gal-3 is shown 
by AuNP@Fc-Lac, which is able to detect the lectin in nanomolar concentrations. The estimated limit 
of detection (LOD) for AuNP@Fc-Lac was calculated to be −160 nM, which is one and two orders of 
magnitude lower than that for PAMAM@Fc-Lac derivatives 12–14 and monomer Fc-Lac 18, 
respectively (Figure 10). A 20 nM concentration of AuNP@Fc-Lac is slightly more sensitive than a 
6.25 µM concentration of 16-mer 14 to detect Gal-3 at a concentration 15 times lower. Nevertheless, it 
should be noted that unlike the DPV measurements for 18 and 12–14, those for AuNP@Fc-Lac 
involved electrode adsorption. Although the Ps values depend on the concentration of Gal-3, it can 
be observed that 16-mer 14 is the most sensitive PAMAM@Fc-Lac derivative in all tested Gal-3 
concentrations. At a 45 µM concentration of Gal-3, which is above the LOD of the non-metallic Fc-
Lac probes, glycodendrimer 14, with 16 lactose units, is at a 6.25 µM concentration, 1.2-fold more 
sensitive than 4-mer 12 and 8-mer 13 at 25 and 12.5 µM concentrations, respectively. Likewise, the 
sensing ability of 16-mer 14 toward Gal-3, at the mentioned concentrations, is 3.2 times higher than 
that of the monovalent derivative in a solution eight times more concentrated. At lower 15 µM 
concentrations of Gal-3, the ratios of the Ps values for 16-mer 14 and 8-mer 13 are similar to those for 
a higher concentration of Gal-3, but the sensitivity of 4-mer 12 is −1.6-fold and twofold lower than 
that for 8-mer 13 and 16-mer 14, respectively. 
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Figure 9. Sensitivity parameters (Ps) for ferrocene–lactose conjugates 12–14, 18, and AuNP@Fc-Lac 
with increasing concentrations of Gal-3. 
 
Figure 10. Limit of detection (LOD) for ferrocene–lactose conjugates 12–14, 18, and AuNP@Fc-Lac 
(logarithmic scale). The LOD (nM) value for each conjugate is shown over the respective bar. 
4. Conclusions 
We have developed simple and convenient methods for the preparation of electrochemical 
probes for the high sensitivity detection of galectin-3. These probes consist of multivalent 
presentations of lactose–ferrocene conjugates based on poly (amido amine) dendrimers and gold 
nanoparticles, enabling enhanced galectin-3 binding affinity and multielectron exchange, resulting 
in an important improvement of electrochemical sensing abilities. Both lactosylferrocenylated 
dendrimers and gold nanoparticles showed a high affinity toward galectin-3 by calorimetric and 
optical methods, respectively, demonstrating that they bind to the lectin through a multivalent 
interaction, despite the monomeric nature of the lectin. Interestingly, the affinity of the multivalent 
conjugates, particularly those with higher valency, is within the range of magnitude of the most 
potent galectin-3 inhibitors, therefore, they can be applied as therapeutic agents. The highest 
sensitivity to galectin-3 by electrochemical methods was shown by lactosylferrocenylated gold 
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nanoparticles, which were able to detect the lectin in nanomolar concentrations at least one order of 
magnitude lower than that needed by the dendrimers. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, UV–visible spectra for 
AuNPs@Fc-Lac preparation; transmission electron microscopy analysis; isothermal titration calorimetry 
experiments for compounds 18, 12, and 14; differential pulse voltammetry titrations for compounds 18, 12, and 
14 with galectin-3; sulfuric acid–phenol assays for compounds 12–14; sensitivity parameters for 12–14, 18, and 
AuNP@Fc-Lac; ICP-OES measurements; mass spectra for compounds 12–14 and 17; 13C-NMR and 1H-NMR 
spectra for compounds 12–14 and 17. 
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